Chicago +1 312 646 5828
On Friday, March 17, 2017, the city of Chicago commissioner of public health published proposed rules to implement the city’s highly publicized pharmaceutical representative licensing ordinance enacted in November 2016. The rules specify reporting and record-keeping obligations, explain professional education
requirements, articulate minimum ethical standards, and establish monetary and other penalties for violations of the ordinance, the rules and the incorporated ethical standards. The public comment period for the proposed rules runs through Sunday, April 2, 2017. The ordinance and finalized rules take effect on July 1, 2017.
Pharmaceutical companies and their representatives must prepare to navigate these new regulations in order to market or promote their products to Chicago health care providers. This article explains Chicago’s proposed Rules in the context of the ordinance, while analyzing what these changes will mean for pharmaceutical companies and their representatives.
Read "Proposed Rules Pose Challenges For Pharma Reps In Chicago"